Stockreport

Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules [Yahoo! Finance]

Shuttle Pharmaceuticals Holdings, Inc.  (SHPH) 
PDF discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy (RT), today announced t [Read more]